These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24728929)

  • 1. Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration.
    Edwards SS; Zavala G; Prieto CP; Elliott M; Martínez S; Egaña JT; Bono MR; Palma V
    Angiogenesis; 2014 Oct; 17(4):851-66. PubMed ID: 24728929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton's jelly-derived mesenchymal stem cells (WJ-MSC).
    Zavala G; Prieto CP; Villanueva AA; Palma V
    Stem Cell Res Ther; 2017 Sep; 8(1):203. PubMed ID: 28962669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Netrin-1 acts as a non-canonical angiogenic factor produced by human Wharton's jelly mesenchymal stem cells (WJ-MSC).
    Prieto CP; Ortiz MC; Villanueva A; Villarroel C; Edwards SS; Elliott M; Lattus J; Aedo S; Meza D; Lois P; Palma V
    Stem Cell Res Ther; 2017 Feb; 8(1):43. PubMed ID: 28241866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells.
    Roy S; Arora S; Kumari P; Ta M
    Cryobiology; 2014 Jun; 68(3):467-72. PubMed ID: 24704519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.
    Shivakumar SB; Bharti D; Subbarao RB; Jang SJ; Park JS; Ullah I; Park JK; Byun JH; Park BW; Rho GJ
    J Cell Biochem; 2016 Oct; 117(10):2397-412. PubMed ID: 27038129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
    Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency of umbilical cord blood- and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing.
    Doi H; Kitajima Y; Luo L; Yan C; Tateishi S; Ono Y; Urata Y; Goto S; Mori R; Masuzaki H; Shimokawa I; Hirano A; Li TS
    Sci Rep; 2016 Jan; 6():18844. PubMed ID: 26728342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms.
    Shohara R; Yamamoto A; Takikawa S; Iwase A; Hibi H; Kikkawa F; Ueda M
    Cytotherapy; 2012 Nov; 14(10):1171-81. PubMed ID: 22900957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of endothelial progenitor cells obtained from human Wharton's jelly using different culture conditions.
    Zayed SA; Gaafar TM; Samy RM; Sabry D; Nasr AS; Maksoud FA
    Biotech Histochem; 2016 Nov; 91(8):532-539. PubMed ID: 27849398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological characteristics of wharton's jelly derived mesenchymal stem cells after cryopreservation].
    Shen JL; Gong LZ; Cen J; Liu Y; Wang LX; Yin WJ; Zhao DF; Ma WN; Huang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):181-7. PubMed ID: 23484716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repair and regeneration of skin injury by transplanting microparticles mixed with Wharton's jelly and MSCs from the human umbilical cord.
    Zhang Y; Hao H; Liu J; Fu X; Han W
    Int J Low Extrem Wounds; 2012 Dec; 11(4):264-70. PubMed ID: 23089966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.
    Zhang L; Zhao YH; Guan Z; Ye JS; de Isla N; Stoltz JF
    Biomed Mater Eng; 2015; 25(1 Suppl):137-43. PubMed ID: 25538064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale expansion of Wharton's jelly-derived mesenchymal stem cells on gelatin microbeads, with retention of self-renewal and multipotency characteristics and the capacity for enhancing skin wound healing.
    Zhao G; Liu F; Lan S; Li P; Wang L; Kou J; Qi X; Fan R; Hao D; Wu C; Bai T; Li Y; Liu JY
    Stem Cell Res Ther; 2015 Mar; 6(1):38. PubMed ID: 25889402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.
    Reppel L; Margossian T; Yaghi L; Moreau P; Mercier N; Leger L; Hupont S; Stoltz JF; Bensoussan D; Huselstein C
    Curr Stem Cell Res Ther; 2014; 9(4):306-18. PubMed ID: 24524785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
    Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
    Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
    Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
    Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.